Battle over drug prices shifts back to the states image

The Hill, October 11, 2017
By Rachel Roubein, quoting Rachel E. Sachs (Academic Fellow Alumna)


Read the full article

From the article:

President Trump has derided pharmaceutical companies as “getting away with murder,” but there’s been little action in Washington to rein in the costs of prescription drugs.

Some states are taking matters into their own hands. California passed a new law that requires pharmaceutical companies to explain a drug’s price tag, and other states are considering similar measures.

“This is not an issue that’s going away, and it’s clear that patients are demanding action on this topic, and if they can’t succeed on the federal level, then they’re going to the states,” said Rachel Sachs, an associate law professor at the Washington University School of Law.

Read more here!

fda health care finance health law policy pharmaceuticals rachel sachs regulation